Sagimet Biosciences, Inc. (SGMT)
5.96
-0.10
(-1.65%)
USD |
NASDAQ |
Dec 26, 16:00
5.95
-0.01
(-0.17%)
After-Hours: 20:00
Sagimet Biosciences Shareholders Equity (Quarterly): 119.26M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Eli Lilly & Co. | 23.79B |
| Madrigal Pharmaceuticals, Inc. | 625.73M |
| HCA Healthcare, Inc. | -5.335B |
| CEL-SCI Corp. | 7.025M |
| AIM ImmunoTech, Inc. | -6.077M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 128.40M |
| Total Liabilities (Quarterly) | 9.146M |
| Debt to Equity Ratio | 0.001 |
| Current Ratio | 13.04 |
| Net Debt Paydown Yield | 0.00% |